Amanda Pedersen - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Amanda Pedersen's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Amanda Pedersen
Verified
News Editor, Medical Device and Diagnostic Industry (MDDI)
Beats
Running Sports.Cycling
Content
By Amanda Pedersen Verified| Medical Device and Diagnostic Industry (MDDI) Verified As expected, tariffs were top of mind for medtech analysts covering Johnson & Johnson's first-quarter earnings call Tuesday morning. CEO Joaquin Duato reminded call participants that in March, J&J announced its commitment to invest more than $55 billion in the US over the next four years in manufacturing, R&D, and technology. "This represents a 25% increase in investment compared to the previous four years," Duato said.
By Amanda Pedersen Verified| Medical Device and Diagnostic Industry (MDDI) Verified Paris, France-based Carmat is now a beat closer to bringing its total artificial heart to the U.S. market. FDA gave Carmat conditional approval to initiate the second cohort of its early feasibility study with the Aeson artificial heart in the United States. The company has been developing the device for years, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure.
Company Info
Medical Device and Diagnostic Industry (MDDI)
London, England, United Kingdom
+44 20 8052 0400